A Study to Test the Safety and Efficacy of Adding Sitagliptin in Patients With Type 2 Diabetes Mellitus (MK0431-074)
Clinical trial NCT00813995 · COMPLETED
Trial details
- NCT number
- NCT00813995
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-09
- Primary completion
- 2010-08-09
- Enrollment
- 395
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.